Content
06/13/2024
Alameda, CA USA
Santa Ana Bio
completed $168 million Series A Round funding. Investors include
Versant Ventures (lead), Google Ventures (lead), RTW Investments, Andreessen Horowitz.
About
Santa Ana Bio is a Bay Area biotech focused on leveraging it’s multiomics and protein engineering platforms to design precision biologics for the treatment of patients with serious immune related diseases.
Startup
Sector:
Biotech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
